BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34699901)

  • 21. Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fisher 344 male rats [Mechanisms of Ageing and Development 123 (2002) 1665-1680].
    Lim IK
    Mech Ageing Dev; 2003 May; 124(5):697-708. PubMed ID: 12825548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgenic expression of tgfb1a induces hepatic inflammation, fibrosis and metastasis in zebrafish.
    Yan C; Yang Q; Gong Z
    Biochem Biophys Res Commun; 2019 Jan; 509(1):175-181. PubMed ID: 30581008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
    Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
    J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic analysis of DEN and CCl
    Zhang Q; Liu Y; Ren L; Li J; Lin W; Lou L; Wang M; Li C; Jiang Y
    Sci Rep; 2024 Apr; 14(1):8013. PubMed ID: 38580754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice.
    He Q; Wang F; Honda T; Lindquist DM; Dillman JR; Timchenko NA; Redington AN
    Tumour Biol; 2017 Oct; 39(10):1010428317737729. PubMed ID: 29072132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of hepatic tumor growth and metastasis by metronomic therapy in a rat model of hepatocellular carcinoma.
    Jang JW; Park ST; Kwon JH; You CR; Choi JY; Jung CK; Bae SH; Yoon SK
    Exp Mol Med; 2011 May; 43(5):305-12. PubMed ID: 21483229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model.
    Yasmin A; Regan DP; Schook LB; Gaba RC; Schachtschneider KM
    Biochimie; 2021 Mar; 182():73-84. PubMed ID: 33444661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.
    Chappell G; Kutanzi K; Uehara T; Tryndyak V; Hong HH; Hoenerhoff M; Beland FA; Rusyn I; Pogribny IP
    Int J Cancer; 2014 Jun; 134(12):2778-88. PubMed ID: 24242335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
    Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
    Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of NF-κB/PI3K/AKT signaling pathway in the protective effect of prunetin against a diethylnitrosamine induced hepatocellular carcinogenesis in rats.
    Li G; Qi L; Chen H; Tian G
    J Biochem Mol Toxicol; 2022 May; 36(5):e23016. PubMed ID: 35239232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
    Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
    Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway.
    Hassoun SM; Abdel-Rahman N; Eladl EI; El-Shishtawy MM
    Tumour Biol; 2017 Jun; 39(6):1010428317707376. PubMed ID: 28651490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.
    Rui W; Xie L; Liu X; He S; Wu C; Zhang X; Zhang L; Yang Y
    J Ethnopharmacol; 2014; 151(1):198-209. PubMed ID: 24247078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-195 vector influence on the development of gradually induced hepatocellular carcinoma in murine model.
    El-Ahwany E; Mansy SS; Zoheiry M; Mourad L; Mahmoud S; Abu-Taleb H; Hassanien M; Hassan M
    Ultrastruct Pathol; 2020 Mar; 44(2):203-210. PubMed ID: 32216509
    [No Abstract]   [Full Text] [Related]  

  • 36. Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation.
    Rodríguez MJ; Sabaj M; Tolosa G; Herrera Vielma F; Zúñiga MJ; González DR; Zúñiga-Hernández J
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fischer 344 male rats.
    Lim IK
    Mech Ageing Dev; 2002 Nov; 123(12):1665-80. PubMed ID: 12470904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy.
    Dolicka D; Sobolewski C; Gjorgjieva M; Correia de Sousa M; Berthou F; De Vito C; Colin DJ; Bejuy O; Fournier M; Maeder C; Blackshear PJ; Rubbia-Brandt L; Foti M
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):597-621. PubMed ID: 32987153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model.
    Fathy AH; Bashandy MA; Bashandy SAE; Mansour AM; Elsadek B
    Can J Physiol Pharmacol; 2017 Dec; 95(12):1462-1472. PubMed ID: 28854340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver.
    Zheng XB; Chen XB; Xu LL; Zhang M; Feng L; Yi PS; Tang JW; Xu MQ
    Cancer Sci; 2017 Mar; 108(3):338-346. PubMed ID: 28100026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.